2023 annual financial data
Rhythm Pharmaceuticals 2023 Operating margin
Rhythm Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -238.1%.
Operating income was -184,357,000 USD and net income was -184,678,000 USD.
Operating cash flow was -136,157,000 USD.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 77,428,000 USD
- Operating income
- -184,357,000 USD
- Net income
- -184,678,000 USD
- Operating cash flow
- -136,157,000 USD